Resultados de la búsqueda 1-10 of 642 for free t4

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine if open surgical resection is superior to thoracoscopic resection for thoracic event-free survival (tEFS) in patients ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with gastric adenocarcinoma with limited low ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with gastric adenocarcinoma with limited low ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with pancreatic adenocarcinoma with ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with gastric adenocarcinoma with limited low ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with gastric adenocarcinoma with limited low ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Additionally, to compare the effectiveness of axicabtagene ciloleucel versus SOCT, as measured by progression-free survival (PFS) and overall survival (OS).

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... free survival (PFS) rate as compared to ACNS0122. Also, to improve disease ... free survival, as compared to doxorubicin alone (Arm 1). Anti-cancer ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess short-term morbidity and disease-free ... free survival (tEFS) in patients with resectable oligometastatic pulmonary ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior ...